CyanVac
Pre-clinicalDevelops intranasal viral vector vaccines for respiratory infectious diseases.
Founded
2014
Focus
Vaccines
About
Develops intranasal viral vector vaccines for respiratory infectious diseases.
Funding History
2Total raised: $15M
Series A$15MUndisclosedMar 15, 2022
GrantUndisclosedNIHJun 15, 2021
Company Info
TypePrivate
Founded2014
LocationAthens, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile